The EX: Emerald Medicham non-holo typically trades between $8 and $18 depending on condition, with lightly played copies averaging around $10–12 and near-mint examples reaching $15–18. This card’s value is driven primarily by its set rarity (non-holo rares from EX: Emerald are moderately scarce), the popularity of Medicham as a collectible, and the classic status of the EX era itself. Unlike the holo version, which commands a premium, the non-holo sits in a middle market segment—affordable enough for casual collectors but still meaningful to those assembling complete set collections.
The EX: Emerald Medicham non-holo holds particular appeal to set builders and vintage Pokemon enthusiasts who specifically target non-holo rares from early 2000s expansions. Unlike modern cards where non-holos are common, older non-holo rares were printed in smaller quantities and represent a legitimate subset of the set. For example, a player assembling an EX: Emerald master set will need this card alongside the holo version, and many collectors view the non-holo as the more challenging pull from booster packs at the time of release.
Table of Contents
- What Sets the EX: Emerald Medicham Apart from Other Medicham Printings?
- How Condition and Grading Dramatically Impact Market Price
- Market Pricing Trends and Where This Card Fits in the Vintage Pokemon Landscape
- Evaluating Value: When to Buy and When to Avoid
- Common Pricing Errors and Market Traps
- The Holo vs. Non-Holo Premium
- Long-Term Stability and Resale Expectations
What Sets the EX: Emerald Medicham Apart from Other Medicham Printings?
Medicham has multiple printings across the Pokemon trading card Game, but the EX: emerald version carries distinct characteristics that affect its market position. The set itself, released in 2004 during the height of the EX-series era, contains a specific card pool that collectors recognize and seek. The non-holo rare version was a pack pull alongside the holo version, and both exist in appreciable quantities but not massive print runs compared to modern sets.
The EX: Emerald Medicham non-holo differs visually from later printings—it features the original EX-series card frame, the distinctive green-tinged color scheme of the Emerald set, and Medicham’s pose and attack descriptions from that specific era. Collectors often compare it to Medicham printings from other early 2000s sets, such as Unseen Forces or Deoxys, and typically find the EX: Emerald version priced competitively in the middle range. A copy from a later non-holo printing (if one exists) would trade for less, while a first-edition or shadowless version would command a significant premium—though those don’t exist for this particular card.
How Condition and Grading Dramatically Impact Market Price
Condition is the single largest price variable for this card. A heavily played copy with edge wear, corner damage, and surface creasing might sell for $4–6, while the same card in mint condition can reach $20–25. This isn’t hyperbole—condition compression in the $8–18 range means that moving from “moderately played” to “lightly played” can double the buyer interest and resale value.
Professional grading services like PSA, Beckett, and CGC assign numerical scores (1–10), and graded copies command premiums that reflect authenticity and condition certainty. A PSA 7 (near-mint) EX: Emerald Medicham non-holo might sell for $25–40, while a PSA 8 (mint) could reach $50–75 depending on market demand. The grading premium exists because buyers are paying for verified condition—there’s no guesswork about centering, surface quality, or corner wear. However, grading costs $50–100+ per card, making it economically irrational for sub-$15 raw cards unless you’re building a premium collection or planning to flip it professionally.
Market Pricing Trends and Where This Card Fits in the Vintage Pokemon Landscape
The EX-series has experienced increased collector interest over the past 3–5 years as millennial fans return to the hobby and as older players reassemble childhood collections. This has lifted prices on non-holo rares from early EX sets, though not uniformly—Medicham is a mid-tier pokemon with a dedicated but not massive fanbase, so it doesn’t command the premiums of Charizard, Rayquaza, or Mewtwo from the same era. Raw market data shows that EX: Emerald non-holo rares typically trade 30–50% below their holo counterparts, establishing a predictable price hierarchy.
Medicham’s non-holo sits squarely in that range. The card remains stable in price rather than volatile, reflecting steady collector demand rather than speculative hype. If you’re monitoring prices across TCGPlayer, eBay sold listings, or local card shops over a 6-month window, you’ll observe the $8–18 range holding firm with occasional outliers—overgraded copies or advantageous buyouts that deviate from the median.
Evaluating Value: When to Buy and When to Avoid
Pricing this card requires comparing current listings to historical sales data, a discipline many casual buyers skip. If you’re considering a purchase, check closed eBay listings (filter for “sold” items) from the past 30–60 days to see what comparable, lightly-played copies actually closed at—not asking prices, but actual transaction prices. Many sellers overprice cards by 20–40%, betting that a small percentage of uninformed buyers will pay the premium.
The trade-off between raw and graded copies is worth considering. For a $10–12 raw card, spending $75 to get it graded PSA 7 makes economic sense only if you’re a high-volume seller or building a museum-quality collection. For a personal collection, a raw lightly-played copy offers better value—you own the card, pay less, and avoid the grading fee and long turnaround times (which can currently run 6–12 weeks at major services). This is especially true for lower-tier Pokemon like Medicham, where the hype premium doesn’t offset the grading cost.
Common Pricing Errors and Market Traps
Many collectors and resellers make the same mistakes when pricing older non-holos. The first error is confusing the non-holo rare with the common or uncommon Medicham from the same set—if you search “EX Emerald Medicham,” you might accidentally list or buy the wrong card. The non-holo *rare* is the one that matters for this article; commons and uncommons from EX: Emerald trade for under $1. Always verify the card number and rarity symbol before committing to a price. A second trap is assuming all non-holos are equally scarce.
Some non-holo rares from EX: Emerald were printed in larger quantities than others, and Medicham was a moderately popular pull. This means you can often find multiple copies at any given time, preventing artificial scarcity from inflating the price. Conversely, if a particular non-holo rare appears rarely in inventory, that’s your signal that it’s actually harder to find—but Medicham doesn’t fall into that category. The final mistake is overpaying for condition without verification. Photos can lie; centering, surface wear, and corner damage look different in natural light versus phone camera flash. Request multiple angles before bidding on anything above $15.
The Holo vs. Non-Holo Premium
The EX: Emerald Medicham holo version typically trades for $25–40 in lightly-played condition, establishing a $15–25 premium over the non-holo. This ratio holds for most non-holo rares in the EX era—holos are 2–4 times more expensive depending on the card’s overall demand.
Set builders often choose the non-holo as a cost-saving measure, deferring the holo purchase for a later date when they’ve saved more budget. This creates a stable secondary market for non-holos, as they serve a genuine purpose in collection-building strategy rather than being “lesser” versions that no one wants.
Long-Term Stability and Resale Expectations
If you purchase an EX: Emerald Medicham non-holo at current prices, expect it to hold value but not appreciate dramatically. The card is neither scarce enough nor popular enough to drive strong appreciation like a Charizard or Blastoise from the same era. However, it’s also unlikely to lose value—demand from set builders and vintage enthusiasts remains steady, and the card’s age (20+ years old) and moderate scarcity provide a floor under pricing.
A copy you buy today at $12 will likely resell for $10–14 in 2–3 years, barring significant shifts in the hobby. This makes it a reasonable long-term hold if you’re building a collection rather than speculating on price appreciation. Resellers targeting quick flips should avoid this card—margins are too thin and demand too constant to generate profitable arbitrage.
- —
